DEXCOM 2023 10-K Filed: Financials & Operations Detailed

Ticker: DXCM · Form: 10-K · Filed: 2024-02-08T00:00:00.000Z

Sentiment: neutral

Topics: earnings, annual-report, financial-performance

TL;DR

**Dexcom's 2023 10-K is out, giving a full financial picture for the past year.**

AI Summary

Dexcom Inc. filed its 10-K on February 8, 2024, for the fiscal year ending December 31, 2023. This filing provides a comprehensive overview of the company's financial performance and operational status, including details on its common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings as of December 31, 2020, and subsequent periods. For investors, this matters because it offers transparency into Dexcom's financial health and growth trajectory, crucial for evaluating its long-term investment potential in the medical instruments sector.

Why It Matters

This filing provides essential financial data for Dexcom, allowing investors to assess the company's performance and make informed decisions about their investment.

Risk Assessment

Risk Level: medium — The medical device industry faces regulatory hurdles and intense competition, posing inherent risks to Dexcom's future growth and profitability.

Analyst Insight

Investors should review the detailed financial statements within the 10-K to understand Dexcom's revenue, expenses, and profitability trends for the fiscal year ending December 31, 2023, and assess its competitive position in the medical device market.

Key Numbers

2023-12-31 — Fiscal Year End Date (Indicates the period covered by the financial statements in the 10-K filing.)
2024-02-08 — Filing Date (Shows when the 10-K was officially submitted to the SEC, providing the most recent public financial data.)
000-51222 — SEC File Number (Unique identifier for Dexcom's filings with the SEC, useful for tracking historical documents.)
116 — Public Document Count (Indicates the number of pages or sections in the filing, suggesting its comprehensive nature.)
3841 — Standard Industrial Classification (SIC) (Categorizes Dexcom as a 'Surgical & Medical Instruments & Apparatus' company, defining its industry.)

Key Players & Entities

DEXCOM INC (company) — the company filing the 10-K
Matthew Dolan (person) — a member mentioned in the filing for Q4 2023
Paul Flynn (person) — a member mentioned in the filing for Q4 2023
Girish Naganathan (person) — a member mentioned in the filing for Q4 2023
Steven R. Pacelli (person) — a member mentioned in the filing for Q4 2023
Barry J. Regan (person) — a member mentioned in the filing for Q4 2023
Kevin R. Sayer (person) — a member mentioned in the filing for Q4 2023
Sadie M. Stern (person) — a member mentioned in the filing for Q4 2023, associated with a December 2023 plan and its termination
Jereme M. Sylvain (person) — a member mentioned in the filing for Q4 2023
December 31, 2023 (date) — the conformed period of report end date

FAQ

What is the primary business classification of DEXCOM INC according to the filing?

DEXCOM INC's Standard Industrial Classification (SIC) is 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.

When was this 10-K filing submitted to the SEC?

This 10-K filing was submitted to the SEC on February 8, 2024, as indicated by the 'FILED AS OF DATE'.

What is the fiscal year end date for the period covered by this 10-K?

The conformed period of report for this 10-K ended on December 31, 2023.

Which individuals are specifically mentioned in relation to the period from October 1, 2023, to December 31, 2023?

Matthew Dolan, Paul Flynn, Girish Naganathan, Steven R. Pacelli, Barry J. Regan, Kevin R. Sayer, Sadie M. Stern (including her December 2023 Plan and its termination), and Jereme M. Sylvain are all mentioned in relation to the period from October 1, 2023, to December 31, 2023.

What is Dexcom's Central Index Key (CIK) as per the filing?

Dexcom's Central Index Key (CIK) is 0001093557.

From the Filing

0001093557-24-000021.txt : 20240208 0001093557-24-000021.hdr.sgml : 20240208 20240208171440 ACCESSION NUMBER: 0001093557-24-000021 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 116 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 24610147 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 10-K 1 dxcm-20231231.htm 10-K dxcm-20231231 false 2023 FY 0001093557 366 366 423 366 366 455 366 366 P3Y P4Y P1Y P1Y 0.0243476 0.006662 0.0061571 http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense P3Y 0001093557 2023-01-01 2023-12-31 0001093557 2023-06-30 iso4217:USD 0001093557 2024-02-01 xbrli:shares 0001093557 dxcm:MatthewDolanMember 2023-10-01 2023-12-31 0001093557 dxcm:MatthewDolanMember 2023-12-31 0001093557 dxcm:PaulFlynnMember 2023-10-01 2023-12-31 0001093557 dxcm:PaulFlynnMember 2023-12-31 0001093557 dxcm:GirishNaganathanMember 2023-10-01 2023-12-31 0001093557 dxcm:GirishNaganathanMember 2023-12-31 0001093557 dxcm:StevenRPacelliMember 2023-10-01 2023-12-31 0001093557 dxcm:StevenRPacelliMember 2023-12-31 0001093557 dxcm:BarryJReganMember 2023-10-01 2023-12-31 0001093557 dxcm:BarryJReganMember 2023-12-31 0001093557 dxcm:KevinRSayerMember 2023-10-01 2023-12-31 0001093557 dxcm:KevinRSayerMember 2023-12-31 0001093557 dxcm:SadieMSternMember dxcm:SadieMSternDecember2023PlanMember 2023-10-01 2023-12-31 0001093557 dxcm:SadieMSternMember dxcm:SadieMSternDecember2023PlanMember 2023-12-31 0001093557 dxcm:SadieMStern2023PlanTerminationMember dxcm:SadieMSternMember 2023-10-01 2023-12-31 0001093557 dxcm:SadieMStern2023PlanTerminationMember dxcm:SadieMSternMember 2023-12-31 0001093557 dxcm:JeremeMSylvainMember 2023-10-01 2023-12-31 0001093557 dxcm:JeremeMSylvainMember 2023-12-31 0001093557 2023-10-01 2023-12-31 0001093557 dxcm:SadieMSternMember 2023-10-01 2023-12-31 0001093557 2023-12-31 0001093557 2022-12-31 iso4217:USD xbrli:shares 0001093557 2022-01-01 2022-12-31 0001093557 2021-01-01 2021-12-31 0001093557 us-gaap:CommonStockMember 2020-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001093557 us-gaap:RetainedEarningsMember 2020-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2020-12-31 0001093557 2020-12-31 0001093557 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001093557 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001093557 us-gaap:CommonStockMember 2021-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001093557 us-gaap:RetainedEarningsMember 2021-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2021-12-31 0001093557 2021-12-31 0001093557 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001093557 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001093557 us-gaap:Accu